Glow stacks are the latest skin-care trend. But there are serious safety concerns to consider before trying one of these ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Beeline Medicines is ...

Revolution Medicines said its pancreatic cancer drug daraxonrasib succeeded in a Phase 3 trial. RevMed said its drug almost doubled the typical length of survival and slashed the risk of death by 60% ...

Jason Mast is a general assignment reporter at STAT focused on the science behind new medicines and the systems and people that decide whether that science ever reaches patients. You can reach Jason ...

Oral peptide drugs are having a moment. FDA approvals in recent months include the first peptide pills for obesity and plaque psoriasis, each providing an alternative to injectable medications.

The U.S. FDA appears poised to allow compounding pharmacies to again sell injectable peptides, a class of products with questionable anti-aging and anti-disease benefits that came under scrutiny for ...

Oral peptide specialist Pinnacle Medicines has secured an $89 million series B with backing from investors in the U.S. and China, bringing the company’s total fundraising haul to $134 million. OrbiMed ...

Gilead Sciences Inc. said it would acquire Ouro Medicines, a closely held company testing novel antibody drugs against autoimmune diseases, for as much as $2.18 billion. Under terms of the deal, ...

While GLP-1 weight loss meds have been a mainstay in pop culture for a few years now, they're potentially about to get even more widespread. Formerly only available as an injection, Wegovy recently ...

At the end of a seemingly ubiquitous commercial for telehealth company Ro, a characteristically flabbergasted Charles Barkley speaks for us all when he remarks, “Wait, you’re telling me they have a ...